Samik Pharmaceutical Company LTD. (KOSDAQ:014950)
South Korea flag South Korea · Delayed Price · Currency is KRW
16,210
-450 (-2.70%)
At close: Jan 29, 2026

KOSDAQ:014950 Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023
Period Ending
Sep '25 Dec '24 Dec '23
Net Income
3,2673,5222,969
Depreciation & Amortization
1,3861,3511,278
Loss (Gain) From Sale of Assets
-2.77-9.5-0.07
Asset Writedown & Restructuring Costs
-23.8-
Loss (Gain) From Sale of Investments
-308.4-300.14-298.32
Stock-Based Compensation
266.53263.5872.69
Provision & Write-off of Bad Debts
-5.18-2.68-65.12
Other Operating Activities
1,4911,391696.68
Change in Accounts Receivable
3,380558.63-1,117
Change in Inventory
-3,612-2,105-55.64
Change in Accounts Payable
-2,256251.69-827.43
Change in Income Taxes
-136.55--3.98
Change in Other Net Operating Assets
-464.27-559.9-400.44
Operating Cash Flow
3,0064,3852,248
Operating Cash Flow Growth
33.70%95.04%-
Capital Expenditures
-951.05-842.32-1,374
Sale (Purchase) of Intangibles
-8.1-5.83-3.14
Investment in Securities
805.62-1,613-120.5
Other Investing Activities
---70
Investing Cash Flow
146.47-2,161-1,868
Long-Term Debt Repaid
--137.56-109.02
Net Debt Issued (Repaid)
-109.38-137.56-109.02
Issuance of Common Stock
672.3672.3-
Dividends Paid
-250.09-281-140.5
Other Financing Activities
-1.47-1.02-
Financing Cash Flow
311.36252.72-249.52
Miscellaneous Cash Flow Adjustments
---0
Net Cash Flow
3,4642,477130.88
Free Cash Flow
2,0553,543874.05
Free Cash Flow Growth
135.11%305.32%-
Free Cash Flow Margin
3.49%6.34%1.71%
Free Cash Flow Per Share
288.12503.91124.52
Cash Interest Paid
2.112.0418.36
Cash Income Tax Paid
458.25205.693.03
Levered Free Cash Flow
-3,382-
Unlevered Free Cash Flow
-3,389-
Change in Working Capital
-3,089-1,854-2,405
Source: S&P Global Market Intelligence. Standard template. Financial Sources.